Skip to main content

Table 7 Incidence of withdrawal bleeding after treatment with EE/CMA or EE/DRSP

From: A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial

 

EE /CMA

n (%)

EE /DRSP

n (%)

Month 1

82 (91.1)

82 (93.2)

Month 3

84 (94.4)

82 (93.2)

Month 6

88 (98.9)

88 (98.9)

  1. Note: No significant difference between treatment groups